The IDIBAPS research group Pathogenesis of neuronal autoimmune diseases, led by Josep Dalmau, and the company EUROIMMUN Medizinische Labord1
The publication collects the latest advances in neurology since 2002 and in the commemoration of its twentieth anniversary highlights the guidelines1
The analysis of two cohorts from the United Kingdom and Catalonia concluded that at least one dose of vaccine does not increase the risk of suffering1
Researchers from the Hospital Clínic-IDIBAPS, the Research Institute of the Hospital de Sant Pau – IIB Sant Pan and the CIBERER confirm that the mole1
For the first time it has been confirmed that some patients with autoimmune encephalitis of unknown origin produce autoantibodies against a subunit o1
